
Investing.com – Denmark stocks were lower after the close on Tuesday, as losses in the Software&Computer Services, Financials and Technology sectors led shares lower.
At the close in Copenhagen, the OMX Copenhagen 20 fell 0.61%.
The best performers of the session on the OMX Copenhagen 20 were ISS A/S (CSE:ISS), which rose 2.21% or 2.85 points to trade at 131.90 at the close. Meanwhile, Novozymes A/S B (CSE:NZYMb) added 1.45% or 5.10 points to end at 356.40 and Chr Hansen Holding A/S (CSE:CHRH) was up 1.38% or 7.40 points to 542.80 in late trade.
The worst performers of the session were GN Store Nord (CSE:GN), which fell 6.28% or 11.35 points to trade at 169.30 at the close. Genmab (CSE:GMAB) declined 3.35% or 66.00 points to end at 1,901.50 and Ambu A/S (CSE:AMBUb) was down 1.90% or 2.20 points to 113.60.
Falling stocks outnumbered advancing ones on the Copenhagen Stock Exchange by 87 to 52 and 22 ended unchanged.
Shares in Genmab (CSE:GMAB) fell to 52-week lows; falling 3.35% or 66.00 to 1,901.50.
Crude oil for March delivery was up 0.39% or 0.29 to $75.05 a barrel. Elsewhere in commodities trading, Brent oil for delivery in March rose 0.10% or 0.08 to hit $80.14 a barrel, while the February Gold Futures contract rose 0.14% or 2.85 to trade at $2,025.05 a troy ounce.
USD/DKK was up 0.39% to 6.88, while EUR/DKK unchanged 0.03% to 7.46.
The US Dollar Index Futures was up 0.36% at 103.49.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.